14
May
2008
It is not the first, will not be the last, name change that is. Alphasniffer (Boulder) has announced a new corporate identity, introducing…BiOptix. This modification in moniker echoes how the Colorado life science ecosystem is certainly maturing from a research and discovery engine to the logical progression of more of a commercialization focus, this second [...]
11
Mar
2008
What do you get when combing Colorado-based Nobel Laureate technology (Dr. John Hall, 2005-Physics) with Colorado-based All-Star management (Dr. Bill Freytag, Chair & CEO Aspreva Pharma, Chair & CEO Myogen)? Answer…alphsniffer…who announced the appointment of Dr. J. William Freytag as the new Chairman of the Board of Directors. Congratulations to Founder and CEO Misha Plam, [...]
17
Oct
2007
AlphaSniffer has developed a highly-sensitive biosensor for detection of trace amounts (~pg/mm2) of bacteria, viruses, proteins, nucleic acids, antibodies and other biological and chemical agents in real-time and with minimal human intervention. Recently they were awarded a $200,000 SBIR grant by the NIH to develop its compact, label free, sensitive and rel-time platform that is [...]
16
Jul
2007
AlphaSnifer, developer of highly sensitive biosensors for the detection of trace amounts (~pg/mm^2) of bacteria, viruses, proteins, nucleic acids, antibodies and other biological and chemical agents, in real time, announced they received U.S. Patent #7,233,396, “Polarization based interferometric detector”. In addition, as Dr. Misha Plam, President and CEO of AlphaSniffer, gears up to raise a [...]
01
May
2007
AlphaSniffer, LLC (Boulder) was founded in 2003 by Dr. Misha Plam. AlphaSniffer has developed a highly-sensitive biosensor for the detection of trace amounts (picograms) of bacteria, viruses, proteins, nucleic acids, antibodies and other biological and chemical agents in real-time and with minimal human intervention. Dr. Plam is the former founder, CEO, President and Chairman of [...]